SSKN News and Press, Strata Skin Sciences Inc. From 03/02/23

HORSHAM, Pa., March 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the launch of the new XTRAC ® ...

A medical technology company, STRATA Skin Sciences ( SSKN ) had been notified by Nasdaq that it has regained compliance with the minimum bid price rule. recently, the company laid out FY 2022 revenue expectations . For further details see: STRATA Skin Sciences regains Na...

HORSHAM, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it had been notified by Nasdaq that...

HORSHAM, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that Joel L. Cohen, MD (FAAD, FACMS), Di...

Unaudited, preliminary revenue within the range of $35-$36 million Record revenue represents approximately 17-19% growth over full year 2021 HORSHAM, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, c...

HORSHAM, Pa., Jan. 13, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced a poster titled “Advancement of P...

HORSHAM, Pa., Jan. 09, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced an exclusive agreement with MINO Labs, a...

HORSHAM, Pa., Dec. 02, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the company will present at the Cantor M...

STRATA Skin Sciences, Inc. (SSKN) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Nicole Jones – Investor Relations Bob Moccia – Chief Executive Officer Chris Lesovitz – Chief Financial Officer Conferen...

Strong revenue in the third quarter 2022 of $9.4 million, a 22% increase over the third quarter of 2021 Strong international sales of $3.3 million, an 82% increase over the third quarter of 2021 Announced U.S. commercial launch of TheraClear ® X acne the...